{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:31Z","timestamp":1790223391227,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5052,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1046\/j.1523-1747.2002.01646.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:01:30Z","timestamp":1047448890000},"page":"366-371","source":"Crossref","is-referenced-by-count":23,"title":["Synergistic Enhancement of Cell-Mediated Immunity by Interleukin-12 Plus Interleukin-2: Basis for Therapy of Cutaneous T Cell Lymphoma"],"prefix":"10.1016","volume":"118","author":[{"given":"Mohamed H.","family":"Zaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wysocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Everetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0010","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.178.4.1223","article-title":"Antitumor and antimetastatic activity of interleukin 12 against tumors","volume":"178","author":"Brunda","year":"1993","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI116161","article-title":"Selective modulation of human natural killer cells in very prolonged infusion of low dose recombinant interleukin 2","volume":"91","author":"Caligiuri","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0020","doi-asserted-by":"crossref","DOI":"10.1084\/jem.173.4.869","article-title":"Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers","volume":"173","author":"Chan","year":"1991","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0025","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V88.4.1383.bloodjournal8841383","article-title":"S\u00e9zary syndrome T-cell clones display T-helper 2 cytokines and the accessory factor-1 (interferon-gamma receptor beta-chain)","volume":"88","author":"Dummer","year":"1996","journal-title":"Blood"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0190-9622(80)80385-9","article-title":"Cutaneous T cell lymphoma: mycosis fungoides, S\u00e9zary syndrome, and other variants","volume":"2","author":"Edelson","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0008-8749(92)90011-D","article-title":"Regulation of human cytolytic lymphocyte responses by interleukin 12","volume":"143","author":"Gately","year":"1992","journal-title":"Cell Immunol"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0040","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood.V91.4.1341","article-title":"Altered interleukin-12 responsiveness in Th1 and Th2 cells associated with the differential activation of STAT5 and STATI","volume":"91","author":"Gollob","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0045","first-page":"1678","article-title":"Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response","volume":"6","author":"Gollob","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI110062","article-title":"Cell surface differentiation antigens of the malignant T cell in S\u00e9zary syndrome and mycosis fungoides","volume":"67","author":"Haynes","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/291335a0","article-title":"Interleukin-2 augments natural killer cell activity","volume":"291","author":"Henney","year":"1981","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0060","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0190-9622(95)90067-5","article-title":"CD8-positive tumor-infiltrating lymphocytes influence the long term survival of patients with mycosis fungoides","volume":"32","author":"Hoppe","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0065","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1084\/jem.188.9.1603","article-title":"Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect","volume":"188","author":"Koblish","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0070","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1084\/jem.177.4.1199","article-title":"Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells","volume":"177","author":"Manetti","year":"1993","journal-title":"Exp Med"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0075","first-page":"131","article-title":"Cutaneous T cell lymphoma","volume":"1","author":"Murphy","year":"1988","journal-title":"Adv Pathol"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0080","doi-asserted-by":"crossref","first-page":"14002","DOI":"10.1073\/pnas.93.24.14002","article-title":"A functional interleukin 12 receptor complex is composed of two beta-type: cytokine receptor subunits","volume":"93","author":"Presky","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.175.3.779","article-title":"Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF","volume":"175","author":"Robertson","year":"1992","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0090","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0889-8588(18)30054-6","article-title":"The immunopathogenesis of cutaneous T-cell lymphoma","volume":"9","author":"Rook","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archderm.1993.01680250098016","article-title":"The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by S\u00e9zary T cells","volume":"129","author":"Rook","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0100","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.154.3.1491","article-title":"IL-12 reverses cytokine and immune abnormalities in S\u00e9zary syndrome","volume":"154","author":"Rook","year":"1995","journal-title":"J Immunol"},{"issue":"Suppl. 1","key":"10.1046\/j.1523-1747.2002.01646.x_bb0105","first-page":"16","article-title":"Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis","volume":"107","author":"Rook","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0110","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","article-title":"Interleukin-12 therapy of cutaneous T-cell lymphoma induced lesion regression and cytotoxic T-cell responses","volume":"94","author":"Rook","year":"1999","journal-title":"Blood"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0115","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.160.4.1147","article-title":"Response of resting human peripheral blood natural killer cells to interleukin 2","volume":"160","author":"Trinchieri","year":"1984","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by S\u00e9zary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0130","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V95.10.3183","article-title":"Interleukin-2 enhances the response of natural killer cells to interleukin 12 through up-regulation of the interleukin-12 receptor and STAT4","volume":"95","author":"Wang","year":"2000","journal-title":"Blood"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0135","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1182\/blood.V97.12.3860","article-title":"Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation","volume":"97","author":"Wang","year":"2001","journal-title":"Blood"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM198508293130903","article-title":"Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy","volume":"313","author":"Weiss","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jnci\/88.1.38","article-title":"Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma","volume":"88","author":"Wigginton","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1046\/j.1523-1747.2002.01646.x_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.0022-202x.2001.01354.x","article-title":"Dysregulation of lymphocyte interleukin-12 receptor expression in S\u00e9zary syndrome","volume":"117","author":"Zaki","year":"2001","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15415751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15415751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T23:56:37Z","timestamp":1682121397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15415751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0022202X15415751"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2002.01646.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}